In a newly published article, researchers, including Nathaniel Chin, MD, created a guide for clinicians to help remove barriers to early detection and diagnosis of cognitive impairments.
Carey Gleason, PhD, MS, and her research team’s African Americans Fighting Alzheimer's in Midlife (AA-FAIM) study is entering its second, five-year cycle and they are focused on making Alzheimer’s research more inclusive.
Maria Mora Pinzon, MD, MS, FACPM, was recently appointed to assistant professor on the tenure track in the Division of Geriatrics and Gerontology at the University of Wisconsin School of Medicine and Public Health.
The Wisconsin Alzheimer's Disease Research Center gratefully recognizes, along with the nation, that February is the traditional Black History Month celebration to acknowledge the contributions of African Americans to the United States of America.
Researchers from the University of Wisconsin–Madison and Wisconsin Alzheimer’s Disease Research Center (ADRC) recently presented at the 15th Annual Edition of the Human Amyloid Imaging (HAI) conference.
The Wisconsin Alzheimer’s Disease Research Center (ADRC) is pleased to announce three Developmental Projects awardees, selected for their research targeting Alzheimer’s disease and related dementias.
Cynthia Carlsson, MD, MS, was recently interviewed by CBS 58 News in Milwaukee about the U.S. Food and Drug Administration (FDA) approval of Leqembi (lecanemab), which showed a reduction of clinical decline in a study of people with early Alzheimer’s disease.